Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|August 15, 2022
The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistanceRun-Ze Li, Xuan-Run Wang, Jian Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 17, 2021
Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIaFang-Yuan Zhang, Run-Ze Li, Cong Xu, et al.
Cell Death & Disease|October 30, 2019
MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancerFu-Gang Duan, Mei-Fang Wang, Ya-Bing Cao, et al.
NPJ Precision Oncology|March 29, 2025
Taurine and proline promote lung tumour growth by co-regulating Azgp1/mTOR signalling pathwayTu-Liang Liang, Ying Chen, Nan-Jie Zhou, et al.
Journal of Cancer Research and Clinical Oncology|April 6, 2020
Prognostic significance of tumor poliovirus receptor and CTLA4 expression in patients with surgically resected non-small-cell lung cancerHui You, Yi-Zhong Zhang, Huan-Ling Lai, et al.
Journal of Advanced Research|September 7, 2024
Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironmentTu-Liang Liang, Hu-Dan Pan, Pei-Yu Yan, et al.
Nature Communications|August 22, 2023
Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapyElaine Lai-Han Leung, Run-Ze Li, Xing-Xing Fan, et al.
Translational Oncology|November 20, 2020
Early lung cancer diagnostic biomarker discovery by machine learning methodsYing Xie, Wei-Yu Meng, Run-Ze Li, et al.
Pharmacological Research|July 15, 2023
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancerJian Wang, Run-Ze Li, Wen-Jun Wang, et al.
Pharmacological Research|August 22, 2021
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signalingJia-Xin Li, Run-Ze Li, Ao Sun, et al.
Pageof 5